Earnings Feed
Start Free
Home/Filings/4/0001140361-12-030697
4//SEC Filing

Kivel Richard 4

Accession 0001140361-12-030697

CIK 0001228627other
View on SEC.govCompany Profile

Filed

Jun 19, 8:00 PM ET

Accepted

Jun 20, 4:21 PM ET

Size

8.4 KB

Accession

0001140361-12-030697

Insider Transaction Report

Form 4
Period: 2012-06-18
REXAHN PHARMACEUTICALS, INC.RNN
Kivel Richard
Director
Transactions
  • Award

    Stock Options (right-to-buy)

    2012-06-18+20,000→ 20,000 total
    Exercise: $0.38Exp: 2022-06-18→ Common Stock (20,000 underlying)
Holdings

  • Common Stock

    2,500

  • Stock Options (right-to-buy)

    Exercise: $1.19From: 2011-09-17Exp: 2020-09-17→ Common Stock (20,000 underlying)
    20,000

  • Stock Options (right-to-buy)

    Exercise: $1.25From: 2012-06-06Exp: 2021-06-06→ Common Stock (20,000 underlying)
    20,000
Footnotes (1)
  • [F1]These options vest and become exercisable in full on June 18, 2013.

Documents

1 file

Issuer

REXAHN PHARMACEUTICALS, INC.

CIK 0001228627

→
Entity typeother

Related Parties

1
  • filerCIK 0001503757

Filing Metadata

Form type
4
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 4:21 PM ET
Size
8.4 KB
View on SEC.gov